The Sabin Vaccine Institute works to extend the benefits of immunization to all people by enabling vaccine access and uptake. Sabin brings together national government officials, policy makers, immunization specialists, researchers and advocates to supply decision makers with the data and expertise they need to make evidence-based decisions on vaccines. Our work includes a number of diseases, including:
Vaccine introduction, policy and financing are complex issues, and countries must achieve ambitious immunization targets with limited available resources. To make informed decisions for the health of their people, decision makers need accurate, up-to-date information to identify vulnerable populations, assess burden of disease, evaluate vaccine efficacy and cost-effectiveness, and measure the efficiency of immunization programs.
The fourth annual World Pneumonia Day was held on November 12, 2012. World Pneumonia Day was launched in 2009 by a broad coalition of public and nonprofit organizations—including the Sabin Vaccine Institute and PACE—to mobilize efforts to fight a neglected disease that kills more than two million children under age five every year.
Pneumococcal disease kills 1.6 million people each year – including 800,000 children under the age of five - and is the leading cause of preventable death worldwide. Vaccines are available now to safely and effectively protect children and adults against most pneumococcal infections. With increased awareness about this disease, and a commitment to purchase and deliver pneumococcal vaccines to children around the globe, we can save an estimated 5.4 million children’s lives by 2030.
The PACE Global Leadership Award recognizes governments, individuals and organizations that have championed pneumococcal disease prevention and whose actions have contributed toward public policy advances in vaccine introduction.
The Pneumococcal Awareness Council of Experts (PACE), a project of Sabin launched in 2006, focused on pneumococcal disease awareness and prevention, and worked through a variety of mediums to drive forward pneumococcal awareness and advocacy efforts. Working with more than 100 professional medical societies around the globe, PACE informed policymakers about the global threat of pneumococcal disease and worked to secure commitments from countries to combat the disease.
In addition to leading various pneumococcal research studies, Sabin has convened the world’s leading experts in epidemiology and other key public health professionals at regional and country-level symposia. Developed in collaboration with the Pan American Health Organization (PAHO), the U.S. Centers for Disease Control and Prevention (CDC) and PneumoADIP, regional symposia have provided a forum to share the latest pneumococcal research and new prevention strategies.
Pneumococcal disease is a deadly infectious disease that kills 1.6 million people each year, including 800,000 children under age five. Global awareness of this deadly disease, however, remains low. Sabin convenes the world’s leading experts in epidemiology and other key public health professionals at regional and country-level symposia, including the Regional Pneumococcal Symposium. Developed in collaboration with the World Health Organization (WHO), the Pan American Health Organization (PAHO), the U.S.